VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.4129
-0.0171 (-3.98%)
At close: Oct 9, 2025, 4:00 PM EDT
0.4125
-0.0004 (-0.10%)
Pre-market: Oct 10, 2025, 7:31 AM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $10.52 million as of October 10, 2025. Its market cap has decreased by -61.25% in one year.
Market Cap
10.52M
Enterprise Value
-29.10M
1-Year Change
-61.25%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $10.52M, a decrease of -95.42%. That is a compound annual growth rate of -42.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 10.52M | -78.72% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |